ANXA10 and head and neck cancer: Only one previous study has analyzed ANXA10 in head and neck cancer; Shimizu et al. [17] showed that ANXA10 is overexpressed frequently in oral squamous cell carcinomas and that this overexpression is associated with tumor size.